Summary:
Phase 2a Study - Effect of LY3154207 on cognition in Mild - Moderate Parkinson's Disease Dementia (PDD)
Qualified Participants Must:
Have a diagnosos of Parkinson's Disease
Qualified Participants May Receive:
Study drug, study materials
Compensation for time and travel